# Ashot Arzumanyan

> Ashot Arzumanyan is a pre-seed investor at SmartGateVC backing Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [SmartGateVC](https://shizune.co/investors/profile/smartgatevc)
- Location: Yerevan, Armenia
- Total investments: 5
- Last investment: Feb 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ashotarzumanyan/
- X (Twitter): https://twitter.com/ashotvc
- Website: https://x.com/ashotvc

Ashot Arzumanyan is a pre-seed investor at SmartGateVC in Yerevan focused on Biotechnology and Artificial Intelligence. Ashot Arzumanyan is cofounder and partner at SmartGateVC. He holds PhD in Economics from the Yerevan State University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Artificial Intelligence | 2 | 40% |
| SaaS | 1 | 20% |
| Big Data | 1 | 20% |
| Analytics | 1 | 20% |

13 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ladder Bio (formerly ThirdLaw Molecular) | Ladder Bio is a therapeutics company that develops synthetic, ladder-shaped compounds engineered for high specificity and stability. The platform combines rational molecular design with computational discovery to create therapeutics with the potency of biologics but the drug-like stability, oral bioavailability, and cell permeability of smallmolecules. Ladder Bio also sees applications for its Spiroligomer chemistry in diagnostics, where the high-affinity binding and synthetic stability can replace more variable biologics. | $1.5M | Pre-Seed | Feb 13, 2025 |  |
| Vonova | Vonova is developing a breakthrough catheter platform as the first alternative to drilling through the skull for the $2B+ brain interface market—a broad category of interventions addressing chronic neurological disorders with cortical electrodes for both recording and stimulating. The company's flagship product, the Cerebro Atlas System, willprovide neuromodulation therapy for drug-resistant chronic pain without the high risk and discomfort associated with invasive brain surgery. Founded in 2022 by a management team with expertise in catheter device development and neurology, Vonova has issued US patents, demonstrated the procedure's feasibility with clinical key opinion leaders, and received an NIH Blueprint Seed Award. Vonova has also been selected from over 1300 medtech companies to participate in the MedTech Innovator cohort 2024 and accelerate the commercial strategy with a wide network of strategic partners. |  | Pre-Seed | Aug 20, 2024 |  |
| TACTUN | We build industrial controllers that work like a brain for machines such as wind turbines, testing machines, and other industrial machinery. With our platform manufacturers can set up hardware controllers and build industrial machinery software 10 times faster and without coding. |  | Pre-Seed | May 08, 2024 |  |
| Modicus Prime | Bringing Self-Service AI to the Life Sciences |  | Pre-Seed | Oct 07, 2021 |  |
| Pinsight | Pinsight provides a digital platform for leadership assessment and development using simulation-based evaluations and behavioral science methods. The platform conducts virtual business simulations and structured assessments to observe how individuals respond to workplace scenarios. It generates behavioral data and reports that help organizationsevaluate leadership capability, identify potential candidates for leadership roles, and support decisions related to hiring, promotion, succession planning, and employee development. |  | Pre-Seed | Jun 16, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Bowman’s Tower Venture Partners](https://shizune.co/investors/profile/bowman-s-tower-venture-partners) — VC Fund, 1 deal together

## About SmartGateVC

VC Fund · Yerevan, Armenia

SmartGateVC is a SoCal and Armenia based VC with a focus on pre-seed investments in AI. Krisp (the world’s best noise cancellation technology), SuperAnnotate (the fastest annotation platform and services for training AI) are among our investments (27 portfolio companies since 2018). Sierra Ventures, Upfront Ventures, AI Fund, YC, and others areamong our follow-on investors. We invest out of 2 funds and our investors include Tim Draper, One Way Ventures, and other high-profile GPs, entrepreneurs, and professionals.

5 contacts available at SmartGateVC.

| Name | Title | Profile |
| --- | --- | --- |
| Ashot Arzumanyan | Partner | https://shizune.co/investors/profile/ashot-arzumanyan |
| Jack Topdjian | Healthcare, Lifesciences and Medical Devices Venture Partner | https://shizune.co/investors/profile/jack-topdjian |
| Vazgen Hakobjanyan | Partner (Fund I) | https://shizune.co/investors/profile/vazgen-hakobjanyan |
| Areg Alimian | Partner | https://shizune.co/investors/profile/areg-alimian |
| Hambardzum Kaghketsyan | Partner (Fund I) | https://shizune.co/investors/profile/hambardzum-kaghketsyan |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Ashot Arzumanyan invest in?

Ashot Arzumanyan invests primarily in Biotechnology, Artificial Intelligence and SaaS startups, most often at Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ashot Arzumanyan last invest?

The most recent investment recorded for Ashot Arzumanyan closed in Feb 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co